Editorial: Digital biomarkers in testing the safety and efficacy of new drugs in mental health: A collaborative effort of patients, clinicians, researchers, and regulators
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-01-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1107037/full |
| _version_ | 1797955864316870656 |
|---|---|
| author | Johanna Maria Catharina Blom Cristina Benatti Deborah Mascalzoni Deborah Mascalzoni Fabio Tascedda Luca Pani Luca Pani Luca Pani |
| author_facet | Johanna Maria Catharina Blom Cristina Benatti Deborah Mascalzoni Deborah Mascalzoni Fabio Tascedda Luca Pani Luca Pani Luca Pani |
| author_sort | Johanna Maria Catharina Blom |
| collection | DOAJ |
| first_indexed | 2024-04-10T23:39:50Z |
| format | Article |
| id | doaj.art-ddd7baf5d7854724b144e29d9c90fd01 |
| institution | Directory Open Access Journal |
| issn | 1664-0640 |
| language | English |
| last_indexed | 2024-04-10T23:39:50Z |
| publishDate | 2023-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Psychiatry |
| spelling | doaj.art-ddd7baf5d7854724b144e29d9c90fd012023-01-11T10:49:27ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402023-01-011310.3389/fpsyt.2022.11070371107037Editorial: Digital biomarkers in testing the safety and efficacy of new drugs in mental health: A collaborative effort of patients, clinicians, researchers, and regulatorsJohanna Maria Catharina Blom0Cristina Benatti1Deborah Mascalzoni2Deborah Mascalzoni3Fabio Tascedda4Luca Pani5Luca Pani6Luca Pani7Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, ItalyDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, ItalyDepartment of Public Health and Caring Sciences, Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, SwedenInstitute for Biomedicine, EURAC Research, Bolzano, ItalyDepartment of Life Science, University of Modena and Reggio Emilia, Modena, ItalyDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, ItalyDepartment of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Miami, FL, United StatesRelmada Therapeutics, Coral Gables, FL, United Stateshttps://www.frontiersin.org/articles/10.3389/fpsyt.2022.1107037/fulldigital biomarkersdigital phenotypingdigital endpointsmobile sensingremote assessmentcognition |
| spellingShingle | Johanna Maria Catharina Blom Cristina Benatti Deborah Mascalzoni Deborah Mascalzoni Fabio Tascedda Luca Pani Luca Pani Luca Pani Editorial: Digital biomarkers in testing the safety and efficacy of new drugs in mental health: A collaborative effort of patients, clinicians, researchers, and regulators Frontiers in Psychiatry digital biomarkers digital phenotyping digital endpoints mobile sensing remote assessment cognition |
| title | Editorial: Digital biomarkers in testing the safety and efficacy of new drugs in mental health: A collaborative effort of patients, clinicians, researchers, and regulators |
| title_full | Editorial: Digital biomarkers in testing the safety and efficacy of new drugs in mental health: A collaborative effort of patients, clinicians, researchers, and regulators |
| title_fullStr | Editorial: Digital biomarkers in testing the safety and efficacy of new drugs in mental health: A collaborative effort of patients, clinicians, researchers, and regulators |
| title_full_unstemmed | Editorial: Digital biomarkers in testing the safety and efficacy of new drugs in mental health: A collaborative effort of patients, clinicians, researchers, and regulators |
| title_short | Editorial: Digital biomarkers in testing the safety and efficacy of new drugs in mental health: A collaborative effort of patients, clinicians, researchers, and regulators |
| title_sort | editorial digital biomarkers in testing the safety and efficacy of new drugs in mental health a collaborative effort of patients clinicians researchers and regulators |
| topic | digital biomarkers digital phenotyping digital endpoints mobile sensing remote assessment cognition |
| url | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1107037/full |
| work_keys_str_mv | AT johannamariacatharinablom editorialdigitalbiomarkersintestingthesafetyandefficacyofnewdrugsinmentalhealthacollaborativeeffortofpatientscliniciansresearchersandregulators AT cristinabenatti editorialdigitalbiomarkersintestingthesafetyandefficacyofnewdrugsinmentalhealthacollaborativeeffortofpatientscliniciansresearchersandregulators AT deborahmascalzoni editorialdigitalbiomarkersintestingthesafetyandefficacyofnewdrugsinmentalhealthacollaborativeeffortofpatientscliniciansresearchersandregulators AT deborahmascalzoni editorialdigitalbiomarkersintestingthesafetyandefficacyofnewdrugsinmentalhealthacollaborativeeffortofpatientscliniciansresearchersandregulators AT fabiotascedda editorialdigitalbiomarkersintestingthesafetyandefficacyofnewdrugsinmentalhealthacollaborativeeffortofpatientscliniciansresearchersandregulators AT lucapani editorialdigitalbiomarkersintestingthesafetyandefficacyofnewdrugsinmentalhealthacollaborativeeffortofpatientscliniciansresearchersandregulators AT lucapani editorialdigitalbiomarkersintestingthesafetyandefficacyofnewdrugsinmentalhealthacollaborativeeffortofpatientscliniciansresearchersandregulators AT lucapani editorialdigitalbiomarkersintestingthesafetyandefficacyofnewdrugsinmentalhealthacollaborativeeffortofpatientscliniciansresearchersandregulators |